Data completeness
1/8 — Limited
Drug data last refreshed 8h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Sulfadiazine is an oral sulfonamide antibiotic used to treat bacterial and parasitic infections, including toxoplasmosis and certain streptococcal infections. The drug works by inhibiting bacterial folate synthesis, making it bacteriostatic against susceptible organisms. It remains a critical agent for specific infections where resistance patterns or patient tolerance favor its use over newer agents.
Pre-Launch
Pre-launch status suggests limited commercial infrastructure; early-stage teams focused on regulatory completion and market preparation.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Started Jul 2000
600 enrolled
Toxoplasmosis
Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
100 enrolled
Toxoplasmosis, CerebralHIV Infections
Career Relevance
Working on sulfadiazine offers opportunity to drive a pre-launch specialty pharmaceutical with niche, high-value indications. Career growth depends on successful market entry, reimbursement strategy, and expansion into adjacent patient populations.
Regulatory Affairs Specialist
Worked on SULFADIAZINE at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.